Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Testosterone increases muscle mass regardless of DHT conversion blocking.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Hirsutism in women can be a cosmetic issue or a sign of hormonal imbalance, treatable with hormonal and cosmetic methods.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Finasteride may help reduce prostate cancer risk.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

High levels of androgens can cause skin issues like acne, hair loss, and excessive hair growth.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Different hair growth phases affect how follicles respond to X-rays, and hormones like testosterone and dihydrotestosterone play a key role in baldness; transplanted hair can grow on bald scalp areas.

Male pattern hair loss is mainly caused by genetics and hormones, especially DHT.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Mutations in the AR gene cause hair thinning and loss.

Bone Morphogenetic Proteins (BMPs) are important for hair growth, and their decrease due to hormones could lead to hair loss, but adding more BMPs could promote hair growth.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Dermal papilla cells play a key role in hair loss by responding to androgens.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Male accessory sex glands in rats rarely develop tumors and respond to hormones.

Testosterone affects hair loss, acne, and excessive hair growth, and antiandrogens can help treat these conditions.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Androgens are essential for maintaining adult neuromuscular structure.

Androgens shorten hair growth phases, causing finer hair and more severe hair loss in men.